Okusaka, T., Ikeda, K., Kudo, M., Finn, R., Qin, S., Han, K., . . . Kumada, H. (2021). Safety and efficacy of lenvatinib by starting dose based on body weight in patients with unresectable hepatocellular carcinoma in REFLECT. J Gastroenterol.
শিকাগো স্টাইলে সাইটেশনOkusaka, Takuji, et al. "Safety and Efficacy of Lenvatinib By Starting Dose Based On Body Weight in Patients With Unresectable Hepatocellular Carcinoma in REFLECT." J Gastroenterol 2021.
এমএলএ সাইটেশনOkusaka, Takuji, et al. "Safety and Efficacy of Lenvatinib By Starting Dose Based On Body Weight in Patients With Unresectable Hepatocellular Carcinoma in REFLECT." J Gastroenterol 2021.
সতর্কবাণী: সাইটেশন সবসময় 100% নির্ভুল হতে পারে না.